Citation: Lt. Dijkhorstoei et al., DIVERGENT EFFECTS OF ACE-INHIBITION AND CALCIUM-CHANNEL BLOCKADE ON NO-ACTIVITY IN SYSTEMIC AND RENAL CIRCULATION IN ESSENTIAL-HYPERTENSION, Cardiovascular Research, 40(2), 1998, pp. 402-409
Authors:
RABELINK TJ
STROES ESG
BOUTER KP
MORRISON P
Citation: Tj. Rabelink et al., ENDOTHELIN BLOCKERS AND RENAL PROTECTION - A NEW STRATEGY TO PREVENT END-ORGAN DAMAGE IN CARDIOVASCULAR-DISEASE, Cardiovascular Research, 39(3), 1998, pp. 543-549
Authors:
JOLES JA
STROES ESG
WILLEKESKOOLSCHIJN N
RABELINK TJ
KOOMANS HA
Citation: Ja. Joles et al., HYPOALBUMINEMIA INCREASES LYSOPHOSPHATIDYLCHOLINE IN LOW-DENSITY-LIPOPROTEIN (LDL), Journal of the American Society of Nephrology, 8, 1997, pp. 340-340
Authors:
RABELINK TJ
KAASJAGER KAH
STROES ESG
KOOMANS HA
Citation: Tj. Rabelink et al., ENDOTHELIN IN RENAL PATHOPHYSIOLOGY - FROM EXPERIMENTAL TO THERAPEUTIC APPLICATION, Kidney international, 50(6), 1996, pp. 1827-1833
Authors:
STROES ESG
OEMAR B
LUSCHER TF
KOOMANS HA
RABELINK TJ
Citation: Esg. Stroes et al., CYCLOSPORINE-A (CSA) IS ASSOCIATED WITH AN INCREASED NITRIC-OXIDE ACTIVITY IN HUMANS, Kidney international, 50(5), 1996, pp. 1817-1817
Authors:
STROES ESG
KOOMANS HA
DEBRUIN TWA
RABELINK TJ
Citation: Esg. Stroes et al., VASCULAR FUNCTION IN THE FOREARM OF HYPERCHOLESTEROLEMIC PATIENTS OFFAND ON LIPID-LOWERING MEDICATION, Lancet, 346(8973), 1995, pp. 467-471
Authors:
STROES ESG
JOLES JA
CHANG PC
KOOMANS HA
RABELINK TJ
Citation: Esg. Stroes et al., IMPAIRED ENDOTHELIAL FUNCTION IN PATIENTS WITH NEPHROTIC RANGE PROTEINURIA (NS), Kidney international, 48(4), 1995, pp. 1363-1363
Authors:
STROES ESG
JOLES JA
CHANG PC
KOOMANS HA
RABELINK TJ
Citation: Esg. Stroes et al., IMPAIRED ENDOTHELIAL FUNCTION IN PATIENTS WITH NEPHROTIC RANGE PROTEINURIA, Kidney international, 48(2), 1995, pp. 544-550
Authors:
STROES ESG
KOOMANS HA
CHANG PC
RABELINK AJ
Citation: Esg. Stroes et al., ENDOTHELIAL DYSFUNCTION IN NEPHROTIC SYNDROME (NS), Journal of the American Society of Nephrology, 5(3), 1994, pp. 592-592